A MIQE-compliant real-time PCR assay for Aspergillus detection

Area of Science:

• Medical Diagnostics
• Molecular Biology
• Mycology

Background:

• Invasive fungal disease (IFD) poses significant risks to immunocompromised patients.
• Current diagnostic methods for IFD, like culture and microscopy, are often inadequate.
• Polymerase chain reaction (PCR) shows promise for IFD diagnosis but suffers from variable performance due to lack of standardization.

Purpose of the Study:

• To develop and validate a real-time quantitative PCR (qPCR) assay for Aspergillus species detection.
• To ensure the assay adheres strictly to the Minimum Information for the publication of real-time Quantitative PCR Experiments (MIQE) guidelines.
• To provide a robust, sensitive, and specific molecular diagnostic tool for clinical use in diagnosing invasive aspergillosis (IA).

Main Methods:

• Designed a hydrolysis probe-based qPCR assay targeting the 18S rRNA DNA sequence of Aspergillus species.
• Optimized and validated the assay in strict compliance with MIQE guidelines.
• Assessed assay performance, including efficiency, dynamic range, limits of quantification and detection, and specificity against other fungal species.

Main Results:

• The developed qPCR assay demonstrated 100% efficiency (95-107% range) and a dynamic range of at least six orders of magnitude.
• Achieved limits of quantification and detection of 6 and 0.6 Aspergillus fumigatus genomes, respectively.
• Showed no amplification of Candida, Scedosporium, Fusarium, or Rhizopus species, confirming high specificity. Clinical sensitivity was demonstrated in proven IA cases.

Conclusions:

• The MIQE-compliant qPCR assay is a highly efficient, specific, and sensitive tool for detecting Aspergillus species.
• This standardized molecular assay addresses previous limitations in PCR-based diagnostics for invasive fungal disease.
• The assay's robustness makes it suitable for routine clinical diagnosis of invasive aspergillosis.